BeyondSpring sells BeyondSpring Ltd stake to Hong Kong investor in data-for-funding deal
BYSI•BeyondSpring sold all ownership interests in BeyondSpring Ltd. to Biolin Investment in a deal that closed Sept. 30, 2026. Consideration included a perpetual, royalty-free license to DUBLIN-4 trial data generated in mainland China, while the investor committed to fund the trial and delivery of its data.
1. Deal terms
BeyondSpring sold all ownership interests in BeyondSpring Ltd. to Biolin Investment under a share purchase and collaboration agreement that closed Sept. 30, 2026. The noncash consideration was led by a perpetual, royalty-free license to DUBLIN-4 trial data generated in mainland China. The investor committed to fund the trial and delivery of datasets, case report forms and source data. A clawback allows equity to be returned if enrollment targets are missed within three years, including a full return if the shortfall is 90% or more.
